RELIGARE Religare Enterprises Q2 FY26 results (Jul–Sep 2025) and concall
Religare Enterprises Limited reported a mixed Q2 FY26, with consolidated total income growing 5.63% YoY to INR2,082 crores, but PAT declining 33.09% YoY to INR45.9 crores. Care Health Insurance showed strong profitability growth of 113.25% in H1 FY26 and improved combined ratio. Religare Finvest became debt-free with a high CRAR, while Religare Broking and Housing Finance faced revenue declines and losses respectively. The company is focused on leveraging recent capital infusion and strategic initiatives for future growth across its subsidiaries.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue down 73.9%, net profit down 33.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 23 | 10 | 10 | 9 | 6 −74% |
| EBITDA | 76 | -61 | 237 | 15 | 67 −12% |
| Net profit | 69 | -63 | 151 | 8 | 46 −33% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
